Frequently Asked Questions
How genetic-guided recovery works, what we measure, and what stays private.
What is Gene Recovery?
Gene Recovery is a HIPAA-covered service that uses genetic information - primarily pharmacogenomic and recovery-relevant variants - to personalise addiction-recovery support. It does not replace a clinician, sponsor, or treatment programme; it gives them better data to work with.
Is addiction genetic?
Heritability of substance-use disorders is meaningful but partial: roughly 40–60% of liability across decades of twin and family studies, with the remainder explained by environment, trauma, and life circumstances. Genetics shapes risk and treatment response - it does not determine outcome.
What kinds of insights does the report provide?
Three buckets: (1) pharmacogenomics - how you metabolise common addiction-medicine treatments such as buprenorphine, naltrexone, and methadone; (2) variants linked to substance-specific risk patterns (alcohol, opioids, stimulants, nicotine); (3) modifiable factors - sleep, stress response, nutrition, and clinician-actionable items.
Will my employer or insurer see this?
No. Gene Recovery operates under HIPAA controls. Genetic data is encrypted at rest, isolated from your profile, and never shared with employers, insurers, or advertisers. You can export or delete your data at any time.
Can I share the report with my doctor or treatment team?
Yes - we encourage it. Reports include a clinician-summary view with actionable pharmacogenomic flags formatted for medical-record use. You decide who sees what and when.
Does Gene Recovery diagnose addiction?
No. We do not diagnose substance-use disorders. Diagnosis is a clinical decision based on a clinician's evaluation, not a genetic test. We provide context that supports a treatment conversation, not the conclusion of one.
How accurate are the pharmacogenomic predictions?
Pharmacogenomic variants for the major drug-metabolising enzymes (CYP2D6, CYP2C19, CYP3A4) are the strongest evidence in genetics - good enough that the FDA includes pharmacogenomic guidance on hundreds of drug labels. We surface only well-replicated, clinically-actionable variants and label evidence tier on every result.
Do I need to be in formal treatment to use Gene Recovery?
No. The service supports anyone working on recovery, whether through formal treatment, peer support, mutual-aid groups, or self-directed efforts. We provide resources for every path and never gate insights behind a clinical relationship.